Site-specific glycan analysis of the SARS-CoV-2 spike Y Watanabe, JD Allen, D Wrapp, JS McLellan, M Crispin Science 369 (6501), 330-333, 2020 | 1542 | 2020 |
Molecular architecture of the SARS-CoV-2 virus H Yao, Y Song, Y Chen, N Wu, J Xu, C Sun, J Zhang, T Weng, Z Zhang, ... Cell 183 (3), 730-738. e13, 2020 | 975 | 2020 |
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield R Pejchal, KJ Doores, LM Walker, R Khayat, PS Huang, SK Wang, ... Science 334 (6059), 1097-1103, 2011 | 869 | 2011 |
Quantitative mass imaging of single biological macromolecules G Young, N Hundt, D Cole, A Fineberg, J Andrecka, A Tyler, A Olerinyova, ... Science 360 (6387), 423-427, 2018 | 555 | 2018 |
Emerging principles for the therapeutic exploitation of glycosylation M Dalziel, M Crispin, CN Scanlan, N Zitzmann, RA Dwek Science 343 (6166), 1235681, 2014 | 523 | 2014 |
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens KJ Doores, C Bonomelli, DJ Harvey, S Vasiljevic, RA Dwek, DR Burton, ... Proceedings of the National Academy of Sciences 107 (31), 13800-13805, 2010 | 434 | 2010 |
Exploitation of glycosylation in enveloped virus pathobiology Y Watanabe, TA Bowden, IA Wilson, M Crispin Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (10), 1480-1497, 2019 | 433 | 2019 |
Trimeric HIV-1-Env structures define glycan shields from clades A, B, and G GBE Stewart-Jones, C Soto, T Lemmin, GY Chuang, A Druz, R Kong, ... Cell 165 (4), 813-826, 2016 | 419 | 2016 |
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity ME Ackerman, M Crispin, X Yu, K Baruah, AW Boesch, DJ Harvey, ... The Journal of clinical investigation 123 (5), 2183-2192, 2013 | 387 | 2013 |
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Y Watanabe, ZT Berndsen, J Raghwani, GE Seabright, JD Allen, ... Nature communications 11 (1), 2688, 2020 | 351 | 2020 |
Glycoprotein structural genomics: solving the glycosylation problem VT Chang, M Crispin, AR Aricescu, DJ Harvey, JE Nettleship, JA Fennelly, ... Structure 15 (3), 267-273, 2007 | 345 | 2007 |
Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes SW De Taeye, G Ozorowski, AT de la Peña, M Guttman, JP Julien, ... Cell 163 (7), 1702-1715, 2015 | 342 | 2015 |
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... Thorax 75 (12), 1089-1094, 2020 | 328* | 2020 |
Contrasting IgG structures reveal extreme asymmetry and flexibility EO Saphire, RL Stanfield, MDM Crispin, PWHI Parren, PM Rudd, ... Journal of molecular biology 319 (1), 9-18, 2002 | 299 | 2002 |
Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein AJ Behrens, S Vasiljevic, LK Pritchard, DJ Harvey, RS Andev, SA Krumm, ... Cell reports 14 (11), 2695-2706, 2016 | 271 | 2016 |
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers T Tokatlian, BJ Read, CA Jones, DW Kulp, S Menis, JYH Chang, ... Science 363 (6427), 649-654, 2019 | 253 | 2019 |
The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade C Bonomelli, KJ Doores, DC Dunlop, V Thaney, RA Dwek, DR Burton, ... PloS one 6 (8), e23521, 2011 | 250 | 2011 |
Structural constraints determine the glycosylation of HIV-1 envelope trimers LK Pritchard, S Vasiljevic, G Ozorowski, GE Seabright, A Cupo, R Ringe, ... Cell reports 11 (10), 1604-1613, 2015 | 190 | 2015 |
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo M Medina-Ramírez, F Garces, A Escolano, P Skog, SW de Taeye, ... Journal of Experimental Medicine 214 (9), 2573-2590, 2017 | 162 | 2017 |
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184 (5), 1188-1200. e19, 2021 | 158 | 2021 |